President of U.S. Surgical and Global Product & Enabling Technologies, Enovis
Search every verified Tim Czartoski interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Tim Czartoski, president of U.S. Surgical and Global Product & Enabling Technologies at Enovis, delivered a talk in September 2022 at the AHF conference titled "The Usefulness of Technology – A Perspective from Industry." During the presentation, he discussed how companies evaluate and invest in medical technology. He noted that the price of technology tends to decrease over time, using the example of a Toyota Camry whose cost remained around $21,000 over 20 years despite significant digital upgrades. Czartoski stated that traditional valuation models like discounted cash flow are inadequate for technology because indirect returns are difficult to predict, and companies must instead place bets on which technologies will shift the "s-curve" of innovation. Czartoski also addressed challenges related to data in healthcare. He said that 90 percent of big data projects fail due to a lack of clear definitions for data needs and use cases. He emphasized the importance of data integrity, security, and patient ownership of data, and noted that regulatory pathways through the FDA remain a challenge. He described Johnson & Johnson's approach to innovation as relying on an open platform that includes global innovation centers
“The price of technology comes down over time. This Camry versus the first one connected with whatever she wants to do with her iPhone, lots of technology, completely digital in 2016. We've jumped the s-curve of technology in cars; we've gone up the s-curve and evolved with cars—they became more connected.”
“Technology is everywhere and everything that we touch, but it's connected and the connected part of it makes a big difference in terms of data collection and what we do with that data. It's not just data; it's what we do with and interpret the insights we generate.”
“90 percent of big data projects fail because there's not a good definition of what data is needed and what the use case is and what you want to accomplish. So when you think about technology, you have to zone in on what's important.”
“The integrity of the data, the cleanliness of the data, how you manage the data, who owns it, how you integrate it—it's not an easy undertaking. Quite frankly, the patient owns their own data, right? Regulatory pathways for all the technologies and getting through the FDA is a challenge.”
A talk by Tim Czartoski of DePuy Synthes entitled The Usefulness of Technology – A Perspective from Industry at the 2022 AHF ...
Sign in to search the full transcript archive, filter by topic, and access every quote from Tim Czartoski.